Article Figures & Data
Tables
Influenza Type Seasona 2004–2005 (n = 392) 2005–2006 (n = 373) 2006–2007 (n = 368) 2007–2008 (n = 496) 2008–2009 (n = 378) 2010–2011 (n = 671) 2011–2012 (n = 588) 2012–2013 (n = 889) 2004–2013 (n = 4155) Matched B Seasonsb (n = 2320) Mismatched B Seasonsc (n = 1835) Influenza A 272 (69.4) 231 (61.9) 311 (84.5) 313 (63.1) 197 (52.1) 451 (67.2) 245 (41.7) 625 (70.3) 2645 (63.7%) 1659 (71.5) 986 (53.7) Influenza B 120 (30.6) 142 (38.1) 57 (15.5) 183 (36.9) 181 (47.9) 220 (32.8) 343 (58.3) 264 (29.7) 1510 (36.3%) 661 (28.5) 849 (46.3) Characteristics Influenza Typea Influenza A (n = 2645) Influenza B (n = 1510) Unadjusted OR/P Boys 1554 (58.8) 875 (57.9) 0.97 (0.85–1.10) Age, y Mean (SD) 3.4 (3.9) 5.0 (4.3) <.0001 Median (IQR) 2.0 (0.6–4.8) 3.9 (1.4–7.2) <.0001 Age group <.0001 0–5 mo 586 (22.2) 170 (11.3) — 6–23 mo 749 (28.3) 305 (20.2) — 24–59 mo 681 (25.7) 423 (28.0) — 5–9 y 406 (15.3) 401 (26.6) — ≥10 y 223 (8.4) 211 (14.0) — Health status .0004 No underlying condition 1342 (50.7) 684 (45.3) — Vaccine-indicated condition 976 (36.9) 651 (43.1) — Other underlying condition 327 (12.4) 175 (11.6) — Ethnic originb White 532/845 (63.0) 337/591 (57.0) — Asian 92/845 (10.9) 60/591 (10.2) — Middle Eastern 51/845 (6.0) 45/591 (7.6) — Black 49/845 (5.8) 74/591 (12.5) — Latin American 17/845 (2.0) 11/591 (1.9) — Aboriginal 81/845 (9.6) 46/591 (7.8) — Other/mixed 23/845 (2.7) 18/591 (3.0) — Data not available 675 419 — Influenza vaccination statusc Received influenza vaccine 98/1504 (6.5) 59/855 (6.9) — Data not available 555 485 — —, Inferential statistical analysis was not conducted.
↵a Data are n (column %) unless otherwise indicated; where fractions are shown, denominator is the number of cases with data available.
↵b Data available only for 2008–2009 season onward; n = 1520 (influenza A), n = 1010 (influenza B).
↵c Includes children ≥6 mo; n = 2059 (influenza A), n = 1340 (influenza B).
Sign or Symptoma Influenza Typeb Seasonal A (n = 2142) Influenza B (n = 1248) Unadjusted OR Adjusted ORc Systemic Fever 1990 (92.9) 1167 (93.5) 1.10 (0.83–1.46) — Headache 78 (3.6) 123 (9.9) 2.89 (2.16–3.88) 1.85 (1.36–2.52) Lethargy 741 (34.6) 465 (37.3) 1.12 (0.97–1.30) — Respiratory Coryza 1277 (59.6) 744 (59.6) 1.00 (0.87–1.15) — Cough 1835 (85.7) 1051 (84.2) 0.89 (0.73–1.08) — Wheezing 476 (22.2) 260 (20.8) 0.92 (0.78–1.09) — Respiratory distress 904 (42.2) 489 (39.2) 0.88 (0.76–1.02) — Apnea 65 (3.0) 37 (3.0) 0.98 (0.65–1.47) — Extrarespiratory Abdominal pain 119 (5.6) 126 (10.1) 1.91 (1.47–2.48) 1.38 (1.05–1.81) Vomiting and/or diarrhea and/or dehydration 1003 (46.8) 569 (45.6) 0.95 (0.83–1.10) — Myalgia 38 (1.8) 102 (8.2) 4.93 (3.37–7.20) 3.19 (2.16–4.72) Arthralgia 10 (0.5) 15 (1.2) 2.59 (1.16–5.79) 1.95 (0.86–4.40) Seizure 238 (11.1) 116 (9.3) 0.82 (0.65–1.04) — Treatment Influenza Typea Seasonal A (n = 2645) Influenza B (n = 1510) Unadjusted OR/P Adjusted OR/Pb Antiviral Antibiotic 400/2643 (15.1) 202/1508 (13.4) 0.87 (0.72–1.04) — Measures of illness severity 1913/2640 (72.5) 1050/1508 (69.6) 0.87 (0.76–1.00) — Respiratory complications Croup 101 (3.8) 51 (3.4) 0.88 (0.62–1.24) — Pneumonia (radiologically confirmed) 595 (22.5) 364 (24.1) 1.09 (0.94–1.27) — Extrarespiratory complications Myositis 18 (0.7) 101 (6.7) 10.46 (6.31–17.35) 6.95 (4.15–11.64) Myocarditis 6 (0.2) 6 (0.4) 1.75 (0.56–5.45) — Hepatitis 24 (0.9) 22 (1.5) 1.61 (0.90–2.89) — Meningitis 6 (0.2) 4 (0.3) 1.17 (0.33–4.15) — Encephalitis 42 (1.6) 36 (2.4) 1.51 (0.97–2.37) — Length of hospital stay, median (IQR), d 3.0 (2.0–5.0) 3.0 (2.0–5.0) 0.60 — Mortality Attributable to influenza 10 (0.4) 16 (1.1) 2.82 (1.28–6.23) 2.65 (1.18–5.94) All-cause 10 (0.4) 18 (1.2) 3.18 (1.46–6.90) 2.95 (1.34–6.49) Admitted to ICU 337 (12.7) 190 (12.6) 0.99 (0.82–1.19) — Required mechanical ventilationc 212 (62.9) 124 (65.3) 1.11 (0.76–1.61) — Required extracorporeal membrane oxygenationc 7 (2.1) 6 (3.2) 1.54 (0.51–4.64) — Length of ICU stay, median (IQR), dc 3.0 (1.0–6.5) 3.0 (1.0–7.0) 0.62 — - TABLE 5
Factors Associated With Radiologically Confirmed Pneumonia in Patients Hospitalized With Influenza B
Radiologically Confirmed Pneumonia Univariate Analysis (n = 1510) Multivariable Analysisa (n = 1510) OR (95% CI) P OR (95% CI) P Boys 0.94 (0.74–1.20) .63 — — Age, y 0.98 (0.95–1.01) .13 — — Age group <.0001 <.0001 0–5 mo Reference Reference 6–23 mo 3.29 (1.94–5.57) <.0001 2.88 (1.69–4.91) <.0001 24–59 mo 3.33 (2.00–5.54) <.0001 2.66 (1.58–4.47) .0002 5–9 y 1.75 (1.03–2.98) .04 1.40 (0.82–2.40) .22 ≥10 y 2.03 (1.15–3.60) .01 1.48 (0.82–2.66) .19 Health status <.0001 <.0001 No underlying condition Reference Reference Vaccine-indicated condition 1.95 (1.51–2.52) <.0001 1.93 (1.47–2.51) <.0001 Other underlying condition 1.27 (0.85–1.90) .25 1.25 (0.83–1.89) .28 —, sex and age (in years) were not included in the multivariable model.
↵a Multivariable model included age group and health status as independent variables.
Univariate Analysis (n = 1510) Univariate Analysis by Health Statusa No Underlying Condition (n = 684) Vaccine-Indicated Conditionb (n = 651) Other Underlying Condition (n = 175) OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P Boys 1.13 (0.83–1.54) .44 —c —c —c —c —c —c Age, y 1.03 (0.99–1.06) .10 —c —c —c —c —c —c Age group .05 .01 .13 .59 0–5 mo Reference Reference — Reference — Reference — 6–23 mo 1.28 (0.70–2.35) .42 3.46 (1.26–9.49) .02 0.33 (0.11–0.96) .04 0.43 (0.11–1.70) .23 24–59 mo 1.46 (0.82–2.58) .20 2.64 (0.95–7.35) .06 0.47 (0.18–1.21) .12 0.62 (0.17–2.26) .47 5–9 y 0.97 (0.53–1.77) .92 1.70 (0.57–5.01) .34 0.29 (0.11–0.78) .01 0.57 (0.16–2.08) .40 ≥10 y 1.91 (1.04–3.54) .04 5.79 (1.91–17.57) .002 0.41 (0.15–1.13) .08 1.13 (0.29–4.44) .86 Health status .002 No underlying condition Reference —d —d —d —d —d —d Vaccine-indicated condition 1.68 (1.20–2.35) .003 —d —d —d —d —d —d Other underlying condition 2.00 (1.25–3.21) .004 —d —d —d —d —d —d ↵a Conducted due to detection of an interaction between age group and health status (P = .045) on multivariable analysis.
↵b For the 0–5 mo age group, a vaccine-indicated condition refers to an underlying condition for which influenza vaccination is particularly recommended in individuals aged ≥6 mo, and does not indicate that influenza vaccination should be given to this age group.
↵c Sex and age (in years) were not included in the multivariable model.
↵d N/A.
Additional Files
Data Supplement